681 results
·
20ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 2
×
Anti-Dna Antibody (Enzyme-Labeled), Antigen, Control
FDA classification
FDA Class 2
·Anti-Dna Antibody (Enzyme-Labeled), Antigen, Control
Oximeter, Reprocessed
FDA classification
FDA Class 2
·Oximeter, Reprocessed
System, Mass Spectrometry, Multiplex Genotyping, Hereditary Thrombophilia Related Mutations
FDA classification
FDA Class 2
·System, Mass Spectrometry, Multiplex Genotyping, Hereditary Thrombophilia Related Mutations
Lynch Syndrome Test System
FDA classification
FDA Class 2
·Lynch Syndrome Test System
Dna-Probe Kit, Human Chromosome X And Y, Bmt Engraftment
FDA classification
FDA Class 2
·Dna-Probe Kit, Human Chromosome X And Y, Bmt Engraftment
Severe Combined Immunodeficiency Disorder (Scid) Newborn Screening Test System
FDA classification
FDA Class 2
·Severe Combined Immunodeficiency Disorder (Scid) Newborn Screening Test System
Antigen, Id, Ha, Cep, Entamoeba Histolytica & Rel. Spp.
FDA classification
FDA Class 2
·Antigen, Id, Ha, Cep, Entamoeba Histolytica & Rel. Spp.
Test 5, 10-Methylenetetrahydrofolate Reductase Mutations, Genomic Dna Pcr
FDA classification
FDA Class 2
·Test 5, 10-Methylenetetrahydrofolate Reductase Mutations, Genomic Dna Pcr
Drug Metabolizing Enzyme Genotyping Systems
FDA classification
FDA Class 2
·Drug Metabolizing Enzyme Genotyping Systems
Dna-Based Test For Minimal Residual Disease For Hematologic Malignancies
FDA classification
FDA Class 2
·Dna-Based Test For Minimal Residual Disease For Hematologic Malignancies
Assay, Proliferation, In Vitro, T Lymphocyte
FDA classification
FDA Class 2
·Assay, Proliferation, In Vitro, T Lymphocyte
Neurologic Disease Risk Assessment Molecular Test
FDA classification
FDA Class 2
·Neurologic Disease Risk Assessment Molecular Test
System, Nucleic Acid Amplification Test, Dna, Antimicrobial Resistance Marker, Direct Specimen
FDA classification
FDA Class 2
·System, Nucleic Acid Amplification Test, Dna, Antimicrobial Resistance Marker, Direct Specimen
Genetic Variant Detection And Health Risk Assessment System
FDA classification
FDA Class 2
·Genetic Variant Detection And Health Risk Assessment System
Spinal Muscular Atrophy Newborn Screening Test System
FDA classification
FDA Class 2
·Spinal Muscular Atrophy Newborn Screening Test System
Autosomal Recessive Carrier Screening Gene Mutation Detection System
FDA classification
FDA Class 2
·Autosomal Recessive Carrier Screening Gene Mutation Detection System
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen
FDA classification
FDA Class 2
·System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen
Serpina1 Variant Detection System
FDA classification
FDA Class 2
·Serpina1 Variant Detection System
Nucleic Acid Amplification Test For The Quantitation Of Epstein-Barr Virus (Ebv) Dna
FDA classification
FDA Class 2
·Nucleic Acid Amplification Test For The Quantitation Of Epstein-Barr Virus (Ebv) Dna
System, Nucleic Acid Amplification Test, Dna, Carbapenem Non-Susceptible Gram Negative Organism, Colony
FDA classification
FDA Class 2
·System, Nucleic Acid Amplification Test, Dna, Carbapenem Non-Susceptible Gram Negative Organism, Colony